CC
Get informed when a big investor buys or sells
+ FollowOvervalued by 250.2% based on the discounted cash flow analysis.
| Market cap | $2.40 Billion |
|---|---|
| Enterprise Value | $5.79 Billion |
| Dividend Yield | $0.35 (2.19%) |
| Earnings per Share | $-2.57 |
| Beta | 1.43 |
| Outstanding Shares | 151,381,215 |
| P/E Ratio | -7.99 |
|---|---|
| PEG | 28.43 |
| Price to Sales | 0.42 |
| Price to Book Ratio | -15.77 |
| Enterprise Value to Revenue | 1 |
| Enterprise Value to EBIT | -8.31 |
| Enterprise Value to Net Income | -20 |
| Total Debt to Enterprise | 0.7 |
| Debt to Equity | -82.92 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4528▲ 14.23% |
|---|---|
| Total Calls | 3,099,500▼ 44.80% |
| Total Puts | 1,403,300▼ 19.49% |
Holdings and activity of institutional investors.
| Ownership % | 93.96%▲ 6.51% |
|---|---|
| Total Invested | $3.00B▲ 3.65% |
| Investors Holding | 495▲ 16.00% |
No data
The Chemours Company is a global leader in Titanium Technologies, Fluoroproducts, and Chemical Solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemi...